Pfizer wins cancer drug patent case against AstraZeneca
The jury found that AstraZeneca's Tagrisso violated Pfizer's Wyeth unit's patent rights.
Source: yahoo.com
Stay updated with breaking news from Pharmaceutical Technology. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The jury found that AstraZeneca's Tagrisso violated Pfizer's Wyeth unit's patent rights.
The NMPA's decision was based on the positive outcomes of the Phase III ATTACK trial.
The development comes after the regulator found increased cancer risk in people exposed to 17-OHPC.
The US National Opioid Settlement is distributing more than $54 billion to communities grappling with the opioid crisis.
There has been several developments in the KRAS inhibitor space, shaping the KRAS inhibitors of the future.